BLACK WEEKSVialer −15% · kit −10% · övrigt −5%med kodFri frakt inom Tyskland från €200

Den här sidan har översatts automatiskt och kan innehålla fel. Har du svenska som modersmål? Vi tar gärna emot din feedback och dina förbättringar.Skicka feedback

The Peptide Desk The Peptide Desk
LL-37, produktfoto
Immune System

LL-37

Immune System

  • Skickas från Tyskland

Beställning

Styckpris - Fri frakt inom Tyskland från 200 € under Black Weeks
  • DHL med spårning
  • Diskret förpackning

4.6 av 5 på Trustpilot73 omdömen

I korthet

LL-37 i siffror

Nyckeltalen från vårt lexikon.

Hela lexikonartikeln
Class
Antimicrobial peptidecathelicidin
Half-life
short
Use
Subcutaneousin mcg
Sizes
5 to 10 mg2 sizes in the shop

Det finns ännu ingen labbanalys för LL-37. Rösta på denLåt testa själv, vi betalar halvaAlla labbanalyser

Kunskap

Allt om LL-37

Bra att ha

Vad du behöver till den

Bakteriostatiskt vatten läggs automatiskt i din varukorg. Sprutor och sudd med ett klick.

Insulinsprutor

10 st. · 5.50 €

Spritsuddar

50 st. · 10 €

Hur mycket vatten?

Enheter på sprutan för din vialstorlek.

Öppna kalkylatorn →

FAQ

Vanliga frågor

Källor till varje svar: lexikonartikel

Har du fortfarande en fråga?

Skriv till oss, vårt team hjälper dig.

Is LL-37 approved or studied in humans?

Not approved, but tested in humans. Only locally though: applied to hard-to-heal leg ulcers (one trial with 34 and one with 148 participants) and as an injection into melanoma metastases (4 participants). There is no trial with LL-37 injected under the skin. The information here describes the state of research.

Where does LL-37 come from in the body?

It is cleaved from the precursor hCAP18. Immune cells make it all the time, skin and mucous membranes mainly during inflammation and infection. In wounds the level rises until about 48 hours after the injury and falls again once the wound has closed. Immune cells also make it depending on vitamin D.

How does LL-37 work?

In two ways. It attaches to the membrane of bacteria and breaks it open. It also attracts immune cells such as neutrophils, monocytes and T cells, via the receptor FPR2 in cell studies. In a skin model it helps wounds close with new skin.

What did the wound trials show?

In the first trial with 34 participants leg ulcers healed about six and three times faster than with placebo at the two lower concentrations, the mean area fell by 68 and 50 percent. The highest concentration worked no better than placebo. The larger phase 2b trial with 148 participants found no overall difference, only a post hoc analysis of large wounds favoured LL-37.

Can LL-37 increase inflammation?

Yes, that has been described. In rosacea cathelicidin is strongly raised in the facial skin and cut differently, in mice these fragments triggered inflammation. In psoriasis LL-37 binds the body's own DNA and makes it visible to certain immune cells, which then release interferon. The entry points this out too.

Which side effects are known?

In both wound trials LL-37 was well tolerated, there were no safety concerns at the wound or in the body. There are no study data for LL-37 injected under the skin. The entry mentions possible reactions at the injection site because LL-37 attacks cell membranes.

Relaterat

Relaterade produkter